36 results on '"Furling, D"'
Search Results
2. FP.44 Exploring the role of MuscleBlind-Like proteins in the regulation of CaVB1 isoform expression in adult skeletal muscle
3. MYASTHENIA & RELATED DISORDERS
4. O.32Genome editing of expanded CTG repeats within the human DMPK gene reduces nuclear RNA foci in muscle of DM1 mice
5. Proteomic evaluation of Pip6a-PMO treatment for myotonic dystrophy type 1
6. Incidence and predictors of venous thromboembolism in inherited myopathies: A higher risk in myotonic dystrophy
7. Survival in myotonic dystrophy type 1 predicted by the new DM1 survival risk score
8. CRISPR/Cas9-mediated genome editing corrects splicing alterations in myotonic dystrophy type 1
9. Association between mutation size and cardiac involvement in myotonic dystrophy type 1: an analysis of the DM1-heart registry
10. Development of a MBNLΔ decoy-based gene therapy for myotonic dystrophy
11. Association between mutation size and cardiac involvement in myotonic dystrophy type 1: when size matters
12. Correlation between mutation size and cardiac involvement in myotonic dystrophy type 1: An analysis of the DM1-heart registry
13. Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy
14. MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206
15. P22 High content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC independent pathway in myotonic dystrophy cell lines
16. P74 Observations on oligo-based therapy for Myotonic Dystrophy
17. P81 Compound screening in myotonic dystrophy
18. Gain of RNA function in pathological cases: Focus on myotonic dystrophy
19. O.6 Antisense approach for myotonic dystrophy
20. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1
21. P1-19 Dérégulation de l’épissage de Tau par MBNL1 dans une Tauopathie
22. G.P.12.01 Immunodetection of myotubularin in human tissues: A diagnostic tool for X-linked myotubular myopathy
23. D.P.4.08 P16 triggers premature senescence of congenital DM1 myoblasts
24. D.P.4.09 Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles
25. D.P.4.10 Muscleblind-like proteins: Similarities and differences in normal and myotonic dystrophy muscle
26. G.P.3.01 The use of immortalised human fibroblasts from a DMD patient to test exon skipping in vivo
27. G.P.14.09 Functional characterization of skeletal muscles in DM1 mice
28. T.O.4 Ribozyme-based gene therapy reverses muscle atrophy in a mouse model of myotonic dystrophy
29. L'IGF-1 induit une augmentation de la taille et du contenu en myosine des myotubes humains
30. The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy
31. IGF-1 induces human myotube hypertrophy by increasing cell recruitment
32. Extended AmplificationIn Vitroand Replicative Senescence: Key Factors Implicated in the Success of Human Myoblast Transplantation
33. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions
34. Defective satellite cells in congenital myotonic dystrophy
35. Glutathione peroxidase-mediated inhibition of DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma cells
36. Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.